Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 19 Apr 24 424B3 Prospectus supplement
- 18 Apr 24 EFFECT Notice of effectiveness
-
12 Apr 24 POS AM Prospectus update (post-effective amendment)
- 15 Feb 24 424B5 Prospectus supplement for primary offering
- 13 Feb 24 424B5 Prospectus supplement for primary offering
- 20 Dec 23 EFFECT Notice of effectiveness
- 19 Dec 23 424B3 Prospectus supplement
- 7 Dec 23 F-3 Shelf registration (foreign)
NAMS similar filings
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement No. 333-275932 on Form S-3 of our report dated February 28, 2024, relating to the financial statements of NewAmsterdam Pharma Company N.V., appearing in the Annual Report on Form 10-K of NewAmsterdam Pharma Company N.V. for the year ended December 31, 2023. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte Accountants B.V. |
Eindhoven, The Netherlands April 12, 2024 |